← Embedded Finance Index 2026

WhizAI

“Can domain-tuned conversational AI replace the traditional BI dashboard for life sciences commercial and medical teams?”

Founded2017
HQSomerset, New Jersey, United States
FoundersRohit Vashisht
Total raisedundisclosed
Latest roundSeries A (2022)
IndustryVertical SaaS / Life Sciences Analytics

The story

WhizAI was founded in 2017 to bring conversational, NLP-based analytics to life sciences commercial teams, replacing dashboard-heavy BI with natural-language queries against pharma data. It scaled a domain-tuned LLM for pharma sales, medical affairs, and market analytics through 2022's Series A. It was subsequently acquired by IQVIA and now operates as 'WhizAI, an IQVIA business,' embedded into IQVIA's Analytics, Insights & Reporting (AIR) suite as the GenAI-powered conversational analytics layer.

Last 12 months

2025

Operating as 'WhizAI, an IQVIA business' — integrated into IQVIA AIR

Product timeline

2017

WhizAI founded in Somerset, NJ to build a cognitive insights platform for life sciences· pivot

2019

Raised $4M seed led by Healthy Ventures to advance BI for life sciences· pivot

2022

Series A led by Shanda Group· pivot

2025

Acquired by IQVIA and rebranded as 'WhizAI, an IQVIA business'; integrated into IQVIA Analytics, Insights & Reporting (AIR)· acquisition

The stack

0 layers disclosed in WhizAI’s embedded-finance stack

Accounting gap: none

WhizAI — frequently asked

Who founded WhizAI?

WhizAI was founded by Rohit Vashisht and is founded in 2017, headquartered in Somerset, New Jersey, United States.

How much funding has WhizAI raised?

WhizAI has raised undisclosed in total (latest round: Series A (2022)).

Benchmark your own stack

Request an embedded finance strategy assessment

Get a read on where your own stack stands against WhizAI and the rest of its category — what they built versus bought, which providers they use, and where the gaps in your own strategy and competitive set actually are.

Your category, mappedHow your stack compares to WhizAI and the other companies in its category.
Build vs. buyWhere a provider relationship would close a gap faster than building it.
A named analyst, not a form replyA short call to scope what's actually worth assessing for you.